Reuters Market Eye - Drugmakers rose on Wednesday, bucking the stock market trend as investors seek defensives.
Ranbaxy Laboratories ended up 4.6 percent, while Sun Pharmaceutical Industries rose 4.59 percent after marking an all-time high of 849.80 rupees.
Glenmark Pharmaceuticals gained 0.4 percent after saying its unit is entering the oncology sector with a new antibody.
Cadila Healthcare closed 1.7 percent higher after U.S. drug regulator gave final approval for Acyclovir tablets, used for the treatment of herpes.
(Reporting by Abhishek Vishnoi)
- Investment & Company Information
- Ranbaxy Laboratories
- Glenmark Pharmaceuticals